Cost-Effectiveness of Dabigatran Etexilate for the Prevention of Stroke and Systemic Embolism in UK Patients With Atrial Fibrillation

Study Questions:

How cost-effective is dabigatran compared to warfarin, aspirin, or no therapy in patients with atrial fibrillation (AF)?